Reverse hybrid therapy for Helicobacter pylori eradication: A systematic review and meta‐analysis
出版年份 2021 全文链接
标题
Reverse hybrid therapy for
Helicobacter pylori
eradication: A systematic review and meta‐analysis
作者
关键词
-
出版物
HELICOBACTER
Volume 26, Issue 2, Pages -
出版商
Wiley
发表日期
2021-02-06
DOI
10.1111/hel.12784
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Recent progress in Helicobacter pylori treatment
- (2020) Yi Hu et al. CHINESE MEDICAL JOURNAL
- Reverse hybrid therapy achieves a similar eradication rate as standard hybrid therapy for Helicobacter pylori infection
- (2020) Te-Fu Lin et al. Journal of the Chinese Medical Association
- Reverse hybrid and concomitant therapies are equivalent in efficacy for the first‐line treatment of H. pylori infection
- (2020) Ping‐I Hsu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus
- (2020) Jyh-Ming Liou et al. GUT
- Short‐term and long‐term impacts of Helicobacter pylori eradication with reverse hybrid therapy on the gut microbiota
- (2019) Ping‐I Hsu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
- (2019) Catherine de Martel et al. Lancet Global Health
- Equivalent Efficacies of Reverse Hybrid and Bismuth Quadruple Therapies in Eradication of Helicobacter pylori Infection in a Randomized Controlled Trial
- (2018) Ping-I Hsu et al. Clinical Gastroenterology and Hepatology
- Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States
- (2018) Hashem B. El-Serag et al. Clinical Gastroenterology and Hepatology
- Prevalence of antibiotic resistance in Helicobacter pylori : a systematic review and meta-analysis in World Health Organization regions
- (2018) Alessia Savoldi et al. GASTROENTEROLOGY
- Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals
- (2018) Wai K. Leung et al. GASTROENTEROLOGY
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
- (2018) Evelina Tacconelli et al. LANCET INFECTIOUS DISEASES
- Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer
- (2018) Il Ju Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
- (2017) James K.Y. Hooi et al. GASTROENTEROLOGY
- Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale
- (2017) Bor-Shyang Sheu et al. HELICOBACTER
- Hybrid Therapy Regimen for Helicobacter Pylori Eradication
- (2016) Li-Ya Zhou et al. CHINESE MEDICAL JOURNAL
- Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report
- (2016) P Malfertheiner et al. GUT
- Role of bismuth in improvingHelicobacter pylorieradication with triple therapy
- (2016) Maria Pina Dore et al. GUT
- Hybrid Therapy as First-Line Regimen forHelicobacter pyloriEradication in Populations with High Antibiotic Resistance Rates
- (2016) Zhiqiang Song et al. HELICOBACTER
- Kyoto global consensus report onHelicobacter pylorigastritis
- (2015) Kentaro Sugano et al. GUT
- A Randomized Controlled Study Comparing Reverse Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Infection
- (2015) Ping-I Hsu et al. MEDICINE
- Hybrid therapy forHelicobacter pyloriinfection: A systemic review and meta-analysis
- (2015) Ping-I Hsu WORLD JOURNAL OF GASTROENTEROLOGY
- Feasibility of Shortening 14-day Hybrid Therapy While Maintaining an ExcellentHelicobacter pyloriEradication Rate
- (2014) Jeng-Yih Wu et al. HELICOBACTER
- Optimized Nonbismuth Quadruple Therapies Cure Most Patients With Helicobacter pylori Infection in Populations With High Rates of Antibiotic Resistance
- (2013) Javier Molina–Infante et al. GASTROENTEROLOGY
- Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
- (2012) Jyh-Ming Liou et al. LANCET
- Modified Sequential Helicobacter pylori Therapy: Proton Pump Inhibitor and Amoxicillin for 14 Days with Clarithromycin and Metronidazole added as a Quadruple (Hybrid) Therapy for the Final 7 Days
- (2011) Ping-I. Hsu et al. HELICOBACTER
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now